Hydrogen sulfide augments the proliferation and survival of human induced pluripotent stem cell-derived mesenchymal stromal cells through inhibition of BKCa

Cytotherapy

Volumn 15, Issue 11, 2013, Pages 1395-1405

  Zhao, Yongxing ^a,b   Wei, Heming ^a,c   Kong, Geraldine ^a   Shim, Winston ^a,c   Zhang, Guangqin ^a,b  

^a DEPARTMENT OF CARDIOLOGY   (Singapore)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

Apoptosis; Human induced pluripotent stem cell derived mesenchymal stromal cells; Large conductance calcium activated K+ channels; PI3K Akt pathway; Proliferation

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 4',6 DIAMIDINO 2 PHENYLINDOLE; BROXURIDINE; CASPASE 8; HYDROGEN SULFIDE; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; PAXILLINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAX; PROTEIN KINASE B;

APOPTOSIS; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BIG CONDUCTANCE CALCIUM ACTIVATED OUTWARD POTASSIUM CURRENT; CELL CYCLE; CELL DIVISION; CELL HYPOXIA; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE REPRESSION; HUMAN; HUMAN CELL; MESENCHYMAL STROMA CELL; PATCH CLAMP; PLURIPOTENT STEM CELL; PLURIPOTENT STEM CELL DERIVED MESENCHYMAL STROMA CELL; POTASSIUM CURRENT; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; WESTERN BLOTTING; WHOLE CELL;

APOPTOSIS; HUMAN INDUCED PLURIPOTENT STEM CELL-DERIVED MESENCHYMAL STROMAL CELLS; LARGE-CONDUCTANCE CALCIUM-ACTIVATED K(+) CHANNELS; PI3K/AKT PATHWAY; PROLIFERATION;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 8; CELL HYPOXIA; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CELL- AND TISSUE-BASED THERAPY; HUMANS; HYDROGEN SULFIDE; INDOLES; INDUCED PLURIPOTENT STEM CELLS; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MESENCHYMAL STROMAL CELLS; PATCH-CLAMP TECHNIQUES; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; POTASSIUM CHANNEL BLOCKERS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 84884985781     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2013.06.004     Document Type: Article

References (42)

1. Wagner W., Bork S., Horn P., Krunic D., Walenda T., Diehlmann A., et al. Aging and replicative senescence have related effects on human stem and progenitor cells. PLoS One 2009, 4:e5846.
2. Crisostomo P.R., Wang M., Wairiuko G.M., Morrell E.D., Terrell A.M., Seshadri P., et al. High passage number of stem cells adversely affects stem cell activation and myocardial protection. Shock 2006, 26:575-580.
3. Kretlow J.D., Jin Y.Q., Liu W., Zhang W.J., Hong T.H., Zhou G., et al. Donor age and cell passage affects differentiation potential of murine bone marrow-derived stem cells. BMC Cell Biol 2008, 9:60.
4. Lian Q., Zhang Y., Zhang J., Zhang H.K., Wu X., Lam F.F., et al. Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Circulation 2010, 121:1113-1123.
5. Wei H., Tan G., Manasi Qiu S., Kong G., Yong P., et al. One-step derivation of cardiomyocytes and mesenchymal stem cells from human pluripotent stem cells. Stem Cell Res 2012, 9:87-100.
6. 2S): the third gas of interest for pharmacologists. Pharmacol Rep 2007, 59:4-24.
7. Dongo E., Hornyak I., Benko Z., Kiss L. The cardioprotective potential of hydrogen sulfide in myocardial ischemia/reperfusion injury (review). Acta Physiol Hung 2011, 98:369-381.
8. Xie X., Sun A., Zhu W., Huang Z., Hu X., Jia J., et al. Transplantation of mesenchymal stem cells preconditioned with hydrogen sulfide enhances repair of myocardial infarction in rats. Tohoku J Exp Med 2012, 226:29-36.
9. Cai W.J., Wang M.J., Moore P.K., Jin H.M., Yao T., Zhu Y.C. The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation. Cardiovasc Res 2007, 76:29-40.
10. Tiong C.X., Lu M., Bian J.S. Protective effect of hydrogen sulphide against 6-OHDA-induced cell injury in SH-SY5Y cells involves PKC/PI3K/Akt pathway. Br J Pharmacol 2010, 161:467-480.
11. Lang F., Foller M., Lang K.S., Lang P.A., Ritter M., Gulbins E., et al. Ion channels in cell proliferation and apoptotic cell death. JMembr Biol 2005, 205:147-157.
12. + conductance. Am J Physiol Cell Physiol 2011, 300:C792-C802.
13. 2+ influx. Acta Physiol Scand 2005, 183:161-169.
14. + channel in enhanced cell proliferation by ATP in brain endothelial cells. JBiol Chem 2006, 281:38430-38439.
15. Zhang J., Chan Y.C., Ho J.C., Siu C.W., Lian Q., Tse H.F. Regulation of cell proliferation of human induced pluripotent stem cell-derived mesenchymal stem cells via ether-a-go-go 1 (hEAG1) potassium channel. Am J Physiol Cell Physiol 2012, 303:C115-C125.
16. 2S signals through protein S-sulfhydration. Sci Signal 2009, 2:72.
17. Tang G., Wu L., Wang R. Interaction of hydrogen sulfide with ion channels. Clin Exp Pharmacol Physiol 2010, 37:753-763.
18. Wei H., Zhang G., Qiu S., Lu J., Sheng J., Manasi, et al. Hydrogen sulfide suppresses outward rectifier potassium currents in human pluripotent stem cell-derived cardiomyocytes. PLoS One 2012, 7:e50641.
19. Hassouna A., Loubani M., Matata B.M., Fowler A., Standen N.B., Galinanes M. Mitochondrial dysfunction as the cause of the failure to precondition the diabetic human myocardium. Cardiovasc Res 2006, 69:450-458.
20. Hsiao W.T., Tsai M.D., Jow G.M., Tien L.T., Lee Y.J. Involvement of Smac, p53, and caspase pathways in induction of apoptosis by gossypol in human retinoblastoma cells. Mol Vis 2012, 18:2033-2042.
21. Wang S., Qu X., Zhao R.C. Clinical applications of mesenchymal stem cells. JHematol Oncol 2012, 5:19.
22. Sun Y.G., Cao Y.X., Wang W.W., Ma S.F., Yao T., Zhu Y.C. Hydrogen sulphide is an inhibitor of L-type calcium channels and mechanical contraction in rat cardiomyocytes. Cardiovasc Res 2008, 79:632-641.
23. 2S and HS(-) donor NaHS inhibits intracellular chloride channels. Gen Physiol Biophys 2009, 28:190-194.
24. Trevisani M., Patacchini R., Nicoletti P., Gatti R., Gazzieri D., Lissi N., et al. Hydrogen sulfide causes vanilloid receptor 1-mediated neurogenic inflammation in the airways. Br J Pharmacol 2005, 145:1123-1131.
25. 2+-activated potassium channels. Circ Res 2011, 108:1439-1447.
26. Coiret G., Borowiec A.S., Mariot P., Ouadid-Ahidouch H., Matifat F. The antiestrogen tamoxifen activates BK channels and stimulates proliferation of MCF-7 breast cancer cells. Mol Pharmacol 2007, 71:843-851.
27. Diem R., Meyer R., Weishaupt J.H., Bahr M. Reduction of potassium currents and phosphatidylinositol 3-kinase-dependent AKT phosphorylation by tumor necrosis factor-(alpha) rescues axotomized retinal ganglion cells from retrograde cell death in vivo. JNeurosci 2001, 21:2058-2066.
28. Xie M.J., Ma Y.G., Gao F., Bai Y.G., Cheng J.H., Chang Y.M., et al. Activation of BKCa channel is associated with increased apoptosis of cerebrovascular smooth muscle cells in simulated microgravity rats. Am J Physiol Cell Physiol 2010, 298:C1489-C1500.
29. Han X., Xi L., Wang H., Huang X., Ma X., Han Z., et al. The potassium ion channel opener NS1619 inhibits proliferation and induces apoptosis in A2780 ovarian cancer cells. Biochem Biophys Res Commun 2008, 375:205-209.
30. Cambien B., Rezzonico R., Vitale S., Rouzaire-Dubois B., Dubois J.M., Barthel R., et al. Silencing of hSlo potassium channels in human osteosarcoma cells promotes tumorigenesis. Int J Cancer 2008, 123:365-371.
31. Abdullaev I.F., Rudkouskaya A., Mongin A.A., Kuo Y.H. Calcium-activated potassium channels BK and IK1 are functionally expressed in human gliomas but do not regulate cell proliferation. PLoS One 2010, 5:e12304.
32. Ca channels. Adv Exp Med Biol 2009, 648:65-72.
33. Sitdikova G.F., Weiger T.M., Hermann A. Hydrogen sulfide increases calcium-activated potassium (BK) channel activityof rat pituitary tumor cells. Pflugers Arch 2010, 459:389-397.
34. Manning B.D., Cantley L.C. AKT/PKB signaling: navigating downstream. Cell 2007, 129:1261-1274.
35. Liu P., Cheng H., Roberts T.M., Zhao J.J. Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov 2009, 8:627-644.
36. Hu Y., Chen X., Pan T.T., Neo K.L., Lee S.W., Khin E.S., et al. Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways. Pflugers Arch 2008, 455:607-616.
37. Datta S.R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997, 91:231-241.
38. Suhara T., Mano T., Oliveira B.E., Walsh K. Phosphatidylinositol 3-kinase/Akt signaling controls endothelial cell sensitivity to Fas-mediated apoptosis via regulation of FLICE-inhibitory protein (FLIP). Circ Res 2001, 89:13-19.
39. Rodrigues M., Griffith L.G., Wells A. Growth factor regulation of proliferation and survival of multipotential stromal cells. Stem Cell Res Ther 2010, 1:32.
40. Chacko S.M., Ahmed S., Selvendiran K., Kuppusamy M.L., Khan M., Kuppusamy P. Hypoxic preconditioning induces the expression of prosurvival and proangiogenic markers in mesenchymal stem cells. Am J Physiol Cell Physiol 2010, 299:C1562-C1570.
41. Zhang H., Hou J.F., Shen Y., Wang W., Wei Y.J., Hu S. Low level laser irradiation precondition to create friendly milieu of infarcted myocardium and enhance early survival of transplanted bone marrow cells. JCell Mol Med 2010, 14:1975-1987.
42. Wisel S., Khan M., Kuppusamy M.L., Mohan I.K., Chacko S.M., Rivera B.K., et al. Pharmacological preconditioning of mesenchymal stem cells with trimetazidine (1-[2,3,4-trimethoxybenzyl]piperazine) protects hypoxic cells against oxidative stress and enhances recovery of myocardial function in infarcted heart through Bcl-2 expression. JPharmacol Exp Ther 2009, 329:543-550.